Harvard Bioscience マネジメント
マネジメント 基準チェック /24
Harvard Bioscienceの CEO はJim Greenで、 Jul2019年に任命され、 の在任期間は 5.33年です。 の年間総報酬は$ 2.39Mで、 24.5%給与と75.5%のボーナス（会社の株式とオプションを含む）で構成されています。 は、会社の株式の4.38%を直接所有しており、その価値は$ 4.12M 。経営陣と取締役会の平均在任期間はそれぞれ2年と7.1年です。
主要情報
Jim Green
最高経営責任者
US$2.4m
報酬総額
| CEO給与比率 | 24.5% |
| CEO在任期間 | 5.3yrs |
| CEOの所有権 | 4.4% |
| 経営陣の平均在職期間 | 2yrs |
| 取締役会の平均在任期間 | 7.1yrs |
経営陣の近況
Recent updates
Is Now An Opportune Moment To Examine Harvard Bioscience, Inc. (NASDAQ:HBIO)?
Nov 07
Harvard Bioscience (NASDAQ:HBIO) Is Making Moderate Use Of Debt
Aug 07Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Shares Not Telling The Full Story
Jul 15Even With A 25% Surge, Cautious Investors Are Not Rewarding Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Performance Completely
Dec 22Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Intrinsic Value Is Potentially 60% Above Its Share Price
Sep 23Harvard Bioscience, Inc. (NASDAQ:HBIO) Stock's 25% Dive Might Signal An Opportunity But It Requires Some Scrutiny
Aug 10An Intrinsic Calculation For Harvard Bioscience, Inc. (NASDAQ:HBIO) Suggests It's 23% Undervalued
Apr 26Here's Why Harvard Bioscience (NASDAQ:HBIO) Can Afford Some Debt
Apr 11Harvard Bioscience GAAP EPS of $0.05 beats by $0.06, revenue of $29.2M misses by $1.2M
Aug 04Harvard Bioscience (NASDAQ:HBIO) Takes On Some Risk With Its Use Of Debt
Jun 08Harvard Bioscience - Dressed Up And Waiting For A Suitor
Mar 15Here's Why Harvard Bioscience (NASDAQ:HBIO) Can Manage Its Debt Responsibly
Feb 16Is Harvard Bioscience (NASDAQ:HBIO) Using Too Much Debt?
Nov 04Is Harvard Bioscience, Inc. (NASDAQ:HBIO) Trading At A 37% Discount?
Oct 01An Intrinsic Calculation For Harvard Bioscience, Inc. (NASDAQ:HBIO) Suggests It's 25% Undervalued
May 04These 4 Measures Indicate That Harvard Bioscience (NASDAQ:HBIO) Is Using Debt Extensively
Apr 19Analysts Are Optimistic We'll See A Profit From Harvard Bioscience, Inc. (NASDAQ:HBIO)
Apr 04Have Insiders Sold Harvard Bioscience, Inc. (NASDAQ:HBIO) Shares Recently?
Mar 20What Kind Of Shareholders Hold The Majority In Harvard Bioscience, Inc.'s (NASDAQ:HBIO) Shares?
Mar 07Harvard Bioscience (NASDAQ:HBIO) Shareholders Have Enjoyed A 92% Share Price Gain
Feb 17An Intrinsic Calculation For Harvard Bioscience, Inc. (NASDAQ:HBIO) Suggests It's 35% Undervalued
Feb 02
CEO報酬分析
| 日付 | 総報酬 | 給与 | 会社業績 |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | -US$14m |
| Jun 30 2024 | n/a | n/a | -US$11m |
| Mar 31 2024 | n/a | n/a | -US$9m |
| Dec 31 2023 | US$2m | US$586k | -US$3m |
| Sep 30 2023 | n/a | n/a | -US$3m |
| Jun 30 2023 | n/a | n/a | -US$5m |
| Mar 31 2023 | n/a | n/a | -US$2m |
| Dec 31 2022 | US$2m | US$574k | -US$10m |
| Sep 30 2022 | n/a | n/a | -US$7m |
| Jun 30 2022 | n/a | n/a | -US$4m |
| Mar 31 2022 | n/a | n/a | -US$6m |
| Dec 31 2021 | US$3m | US$574k | -US$288k |
| Sep 30 2021 | n/a | n/a | -US$2m |
| Jun 30 2021 | n/a | n/a | -US$3m |
| Mar 31 2021 | n/a | n/a | -US$4m |
| Dec 31 2020 | US$3m | US$574k | -US$8m |
| Sep 30 2020 | n/a | n/a | -US$7m |
| Jun 30 2020 | n/a | n/a | -US$8m |
| Mar 31 2020 | n/a | n/a | -US$7m |
| Dec 31 2019 | US$3m | US$265k | -US$5m |
| Sep 30 2019 | n/a | n/a | -US$2m |
| Jun 30 2019 | n/a | n/a | US$432k |
| Mar 31 2019 | n/a | n/a | -US$819k |
| Dec 31 2018 | US$153k | n/a | -US$4m |
| Sep 30 2018 | n/a | n/a | -US$8m |
| Jun 30 2018 | n/a | n/a | -US$8m |
| Mar 31 2018 | n/a | n/a | -US$7m |
| Dec 31 2017 | US$129k | n/a | -US$2m |
報酬と市場: Jimの 総報酬 ($USD 2.39M ) は、 US市場 ($USD 652.28K ) の同規模の企業の平均を上回っています。
報酬と収益: Jimの報酬は増加しましたが、会社は利益を上げていません。
CEO（最高経営責任者
Jim Green (66 yo)
5.3yrs
在職期間
US$2,392,240
報酬
Mr. James W. Green, also known as Jim, has been the Chairman of Harvard Bioscience, Inc. since June 5, 2017 and its Director since April 30, 2015. He serves as President and Chief Executive Officer of Harv...
リーダーシップ・チーム
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 5.3yrs | US$2.39m | 4.38% $ 4.1m | |
| CFO & Treasurer | 1.8yrs | US$571.27k | 0.097% $ 91.0k | |
| Chief Legal Counsel & Corporation Secretary | 2.3yrs | データなし | データなし | |
| Senior Vice President of Global Sales | 1.5yrs | データなし | データなし | |
| Vice President of Global People Operations | no data | データなし | データなし | |
| Corporate Controller | no data | データなし | データなし | |
| Director of Corporate Accounting & SEC Reporting | no data | データなし | データなし |
2.0yrs
平均在職期間
63yo
平均年齢
経験豊富な経営陣: HBIOの経営陣は 経験豊富 であると考えられます ( 2年の平均在職年数)。
取締役
| 名称 | ポジション | 在職期間 | 報酬 | 所有権 |
|---|---|---|---|---|
| President | 9.6yrs | US$2.39m | 4.38% $ 4.1m | |
| Independent Director | 5.2yrs | US$213.09k | 0.52% $ 492.6k | |
| Lead Independent Director | 10yrs | US$223.06k | 1.15% $ 1.1m | |
| Independent Director | 7.1yrs | US$205.45k | 0.57% $ 538.8k | |
| Independent Director | 7.1yrs | US$198.09k | 0.61% $ 572.9k |
7.1yrs
平均在職期間
58yo
平均年齢
経験豊富なボード: HBIOの 取締役会 は 経験豊富 であると考えられます ( 7.1年の平均在任期間)。